remicade and polymyalgia rheumatica - no improvement
- From: Mary Z <mzuschlag@xxxxxxxxx>
- Date: Sat, 15 Oct 2005 08:48:52 -0700
The Incidence of Serious Infections is not Increased in Patients with
Rheumatoid Arthritis Treated with Anti-TNF Drugs Compared to Those
Treated with Traditional DMARDs: Results from a National Prospective
Study
Category: 18. RA treatment ? biologics and gene therapy
Title: Infliximab in the Treatment of Polymyalgia Rheumatica: A Double
Blind, Randomized, Placebo Controlled Study
Category: 32. Vasculitis
Author(s): Carlo Salvarani1, Carlo Manzini2, Giuseppe Paolazzi3, Aldo
Trotta4, Paolo Manganelli5, Marco Cimmino6, Roberto Gerli7,
Mariagrazia Catanoso1, Luigi Boiardi1, Giuseppe Germanò1, Pierluigi
Macchioni1, Fabrizio Cantini8. 1Arcispedale S Maria Nuova, Reggio
Emilia, Italy; 2Policlinico, Modena, Italy; 3Ospedale S Chiara,
Trento, Italy; 4Policlinico S Salvatore, L'Aquila, Italy; 5Ospedale
Maggiore, Parma, Italy; 6Ospedale S Martino, Genova, Italy;
7Policlinico Monteluce, Perugia, Italy; 8Ospedale di Prato, Prato,
Italy
Presentation Number: 1828
Purpose: To compare the efficacy and safety of prednisone plus
infliximab (IFX) and prednisone alone in patients with newly diagnosed
polymyalgia rheumatica (PMR).
Methods: Design: multicenter, double-blind, randomized, placebo-
controlled study. Setting: 7 Italian rheumatology clinics. Patients:
49 patients with newly diagnosed PMR (according to Healey?s criteria).
Primary endpoints: proportion of relapse-free patients through week
22. Relapse was defined as: a flare-up of signs and symptoms of PMR
accompanied by an increased erythrocyte sedimentation rate (> 30 mm/h)
levels and the concomitant increase in the patient?s dose of
corticosteroids (CS).
Conclusions: In this population of newly diagnosed PMR patients, IFX 3
mg/kg administered every 8 weeks after an induction regimen, did not
improve the proportion of relapse-free patients compared to placebo
through week 22. IFX was well tolerated in this cohort of elderly
patients.
Visit my website:
http://www.mzuschlag.com
.
- Prev by Date: Incidence of serious is not increased with anti-tnf use
- Next by Date: breast cancer risk and anti-tnf
- Previous by thread: Incidence of serious is not increased with anti-tnf use
- Next by thread: breast cancer risk and anti-tnf
- Index(es):
Relevant Pages
|